We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
CLOV icon
251
Clover Health Investments
CLOV
$2.25B
$2.25B $4.27 1.39%
HRMY icon
252
Harmony Biosciences
HRMY
$2.25B
$2.25B $38.78 8.93%
NUVB icon
253
Nuvation Bio
NUVB
$2.24B
$2.24B $6.44 4.55%
PVLA
254
Palvella Therapeutics
PVLA
$2.18B
$2.18B $151.99 7.96%
COAG
255
Hemab Therapeutics
COAG
$2.17B
$2.17B $46.52 3.38%
VERA icon
256
Vera Therapeutics
VERA
$2.15B
$2.15B $29.95 7.07%
ADUS icon
257
Addus HomeCare
ADUS
$2.12B
$2.12B $113.66 2.68%
WGS icon
258
GeneDx Holdings
WGS
$2.1B
$2.1B $70.90 4.48%
NEO icon
259
NeoGenomics
NEO
$2.09B
$2.09B $16.29 2.84%
ZLAB icon
260
Zai Lab
ZLAB
$2.09B
$2.09B $18.49 1.71%
BHVN icon
261
Biohaven
BHVN
$2.07B
$2.07B $13.75 2.84%
ADMA icon
262
ADMA Biologics
ADMA
$2.07B
$2.07B $8.91 1.95%
SGRY icon
263
Surgery Partners
SGRY
$2.05B
$2.05B $15.65 2.55%
AVAH icon
264
Aveanna Healthcare
AVAH
$2.04B
$2.04B $9.36 2.6%
MD icon
265
Pediatrix Medical
MD
$2.03B
$2.03B $24.71 5.87%
RAPP
266
Rapport Therapeutics
RAPP
$2.02B
$2.02B $42.20 3.46%
HCM icon
267
HUTCHMED
HCM
$2.01B
$2.01B $11.57 0.17%
NBTX
268
Nanobiotix
NBTX
$2.01B
$2.01B $39.52 1.62%
GHRS icon
269
GH Research
GHRS
$2B
$2B $29.12 3.3%
ATRC icon
270
AtriCure
ATRC
$1.98B
$1.98B $39 0.72%
ZBIO
271
Zenas BioPharma
ZBIO
$1.98B
$1.98B $31.42 0.93%
STOK icon
272
Stoke Therapeutics
STOK
$1.97B
$1.97B $31.67 7.14%
IOVA icon
273
Iovance Biotherapeutics
IOVA
$1.95B
$1.95B $4.36 0.93%
URGN icon
274
UroGen Pharma
URGN
$1.94B
$1.94B $39.92 3.45%
TYRA icon
275
Tyra Biosciences
TYRA
$1.93B
$1.93B $32.53 1.53%
9 10
11
12 13

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.